Literature DB >> 4734250

Development of antibodies to porcine calcitonin during treatment of Paget's disease of bone.

W J Dube, R S Goldsmith, S B Arnaud, C D Arnaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4734250

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  4 in total

Review 1.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

2.  Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin.

Authors:  V Lo Cascio; S Adami; G Galvanini; R Lazzaretto; M Ferrari; D Tartarotti; L A Scuro
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

3.  Long- and short-term side effects and safety of calcitonin in man: a prospective study.

Authors:  S J Wimalawansa
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

4.  Mithramycin therapy in Paget's disease.

Authors:  A S Russell; B C Lentle
Journal:  Can Med Assoc J       Date:  1974-02-16       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.